Lessons learned for surveillance strategies for trachoma elimination as a public health problem, from the evaluation of approaches utilised by Guinea worm and onchocerciasis programmes: A literature review.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Onchocerciasis* ; Public Health*; Dracunculus Nematode/*microbiology ; Trachoma/*epidemiology; Animals ; Databases, Factual ; Disease Eradication ; Dracunculiasis/epidemiology ; Health Surveys ; Humans ; Prevalence ; Trichiasis/epidemiology

Introduction: A number of neglected tropical diseases are targeted for elimination or eradication. An effective surveillance system is critical to determine if these goals have been achieved and maintained. Trachoma has two related but morphologically different presentations that are monitored for elimination, the active infectious form of trachoma and trachomatous trichiasis (TT), the progression of the disease. There are a number of lessons learnt from the Guinea worm surveillance system that are particularly compatible for TT surveillance and the onchocerciasis surveillance system which can provide insights for surveillance of the infectious form of trachoma.
Methods/principal Findings: A literature search of peer-reviewed published papers and grey literature was conducted using PUBMED and Google Scholar for articles relating to dracunculiasis or Guinea worm, onchocerciasis and trachoma, along with surveillance or elimination or eradication. The abstracts of relevant papers were read and inclusion was determined based on specified inclusion and exclusion criteria. The credibility and bias of relevant papers were also critically assessed using published criteria. A total of 41 papers were identified that were eligible for inclusion into the review. The Guinea worm programme is designed around a surveillance-containment strategy and combines both active and passive surveillance approaches, with a focus on village-based surveillance and reporting. Although rumour reporting and a monetary incentive for the identification of confirmed Guinea worm cases have been reported as successful for identifying previously unknown transmission there is little unbiased evidence to support this conclusion. More rigorous evidence through a randomised controlled trial, influenced by motivational factors identified through formative research, would be necessary in order to consider applicability for TT case finding in an elimination setting. The onchocerciasis surveillance strategy focuses on active surveillance through sentinel surveillance of villages and breeding sites. It relies on an entomological component, monitoring infectivity rates of black flies and an epidemiological component, tracking exposure to infection in humans. Challenges have included the introduction of relatively complex diagnostics that are not readily available in onchocerciasis endemic countries and target thresholds, which are practically unattainable with current diagnostic tests. Although there is utility in monitoring for infection and serological markers in trachoma surveillance, it is important that adequate considerations are made to ensure evidence-based and achievable guidelines for their utility are put in place.
Conclusions/significance: The experiences of both the Guinea worm and onchocerciasis surveillance strategies have very useful lessons for trachoma surveillance, pre- and post-validation. The use of a monetary reward for identification of TT cases and further exploration into the use of infection and serological indicators particularly in a post-validation setting to assist in identifying recrudescence would be of particular relevance. The next step would be a real-world evaluation of their relative applicability for trachoma surveillance.
Competing Interests: The authors have declare that no competing interests exist.

Am J Trop Med Hyg. 2018 Jan;98(1):216-220. (PMID: 29141720)
Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120137. (PMID: 23798686)
PLoS Negl Trop Dis. 2018 Oct 23;12(10):e0006897. (PMID: 30352058)
Soc Sci Med. 1996 Jan;42(2):233-43. (PMID: 8928032)
Lancet Glob Health. 2017 Mar;5(3):e250-e251. (PMID: 28089329)
MMWR Morb Mortal Wkly Rep. 2017 Dec 08;66(48):1327-1331. (PMID: 29216028)
PLoS Negl Trop Dis. 2012;6(7):e1746. (PMID: 22860146)
Lancet. 2004 Apr 3;363(9415):1093-8. (PMID: 15064026)
Ann Trop Med Parasitol. 2001 Dec;95(8):821-6. (PMID: 11784436)
Sci Rep. 2017 Nov 8;7(1):15040. (PMID: 29118442)
Sex Transm Dis. 2012 Jan;39(1):46-8. (PMID: 22183846)
Epidemics. 2017 Mar;18:4-15. (PMID: 28279455)
PLoS Negl Trop Dis. 2018 Oct 11;12(10):e0006531. (PMID: 30307939)
PLoS Negl Trop Dis. 2017 Oct 3;11(10):e0005884. (PMID: 28972982)
Health Educ Res. 1992 Dec;7(4):471-85. (PMID: 10148747)
Pan Afr Med J. 2017 Jun 05;27:84. (PMID: 28819505)
PLoS One. 2017 Jun 29;12(6):e0178595. (PMID: 28662043)
Int Health. 2018 Mar 1;10(suppl_1):i54-i59. (PMID: 29471344)
Lancet. 2019 Mar 30;393(10178):1261. (PMID: 30938302)
Infect Dis Poverty. 2016 Jun 27;5(1):66. (PMID: 27349645)
Int Health. 2018 Mar 1;10(suppl_1):i20-i26. (PMID: 29471336)
PLoS Negl Trop Dis. 2009 Jun 16;3(6):e462. (PMID: 19529762)
Clin Microbiol Rev. 2002 Apr;15(2):223-46. (PMID: 11932231)
PLoS Negl Trop Dis. 2018 Mar 15;12(3):e0006249. (PMID: 29543797)
PLoS Negl Trop Dis. 2018 Dec 14;12(12):e0007027. (PMID: 30550537)
PLoS Negl Trop Dis. 2015 Dec 11;9(12):e0004270. (PMID: 26658938)
PLoS Negl Trop Dis. 2015 Feb 25;9(2):e0003555. (PMID: 25714363)
Ethiop Med J. 2017;55(Suppl 1):15-31. (PMID: 28878428)
Lancet Infect Dis. 2008 May;8(5):310-22. (PMID: 18471776)
Diagn Microbiol Infect Dis. 2015 Feb;81(2):102-4. (PMID: 25497459)
Wkly Epidemiol Rec. 2003 Sep 12;78(37):321-3. (PMID: 14526665)
PLoS Med. 2006 Sep;3(9):e371. (PMID: 17002504)
Am J Trop Med Hyg. 2014 Jan;90(1):61-70. (PMID: 24277785)
PLoS Negl Trop Dis. 2019 Jan 28;13(1):e0007127. (PMID: 30689671)
Trop Med Int Health. 2013 Nov;18(11):1344-52. (PMID: 24033501)
Clin Diagn Lab Immunol. 1996 Jan;3(1):98-104. (PMID: 8770512)
Ophthalmic Epidemiol. 2015;22(3):214-25. (PMID: 26158580)
Int Health. 2018 Mar 1;10(suppl_1):i7-i13. (PMID: 29471338)
JAMA Ophthalmol. 2017 Nov 1;135(11):1141-1146. (PMID: 28973295)
Wkly Epidemiol Rec. 2005 Aug 12;80(32):270-6. (PMID: 16116900)
PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2347. (PMID: 23936573)
N Engl J Med. 2008 Apr 24;358(17):1870-1. (PMID: 18434662)
Trends Parasitol. 2015 Nov;31(11):571-582. (PMID: 26458784)
Bull World Health Organ. 2006 Aug;84(8):613-9. (PMID: 16917648)
Am J Trop Med Hyg. 2010 Dec;83(6):1348-51. (PMID: 21118947)
Int Health. 2018 Mar 1;10(suppl_1):i60-i70. (PMID: 29471337)
Clin Infect Dis. 2019 Apr 24;68(9):1588-1595. (PMID: 30169566)
Bull World Health Organ. 1991;69(5):533-40. (PMID: 1835673)
Nat Commun. 2018 Dec 21;9(1):5444. (PMID: 30575720)
MMWR Morb Mortal Wkly Rep. 2011 Jun 10;60(22):744-8. (PMID: 21659983)
J Bacteriol. 2010 Nov;192(22):6017-24. (PMID: 20851898)
PLoS Negl Trop Dis. 2017 Jan 18;11(1):e0005230. (PMID: 28099433)
Int Health. 2018 Mar 1;10(suppl_1):i14-i19. (PMID: 29471341)
Trop Med Int Health. 1997 Jan;2(1):99-103. (PMID: 9018307)
Am J Trop Med Hyg. 2010 Mar;82(3):482-7. (PMID: 20207878)
PLoS Negl Trop Dis. 2016 Jan 15;10(1):e0004352. (PMID: 26771906)
PLoS Negl Trop Dis. 2010 Oct 05;4(10):. (PMID: 20957147)
Ophthalmic Epidemiol. 2001 Jul;8(2-3):109-17. (PMID: 11471080)

Date Created: 20210128 Date Completed: 20210517 Latest Revision: 20210517

20240105

PMC7872237

10.1371/journal.pntd.0009082

33507903